70 related articles for article (PubMed ID: 8090263)
1. [Pharmacodynamic study of mitomycin C mixed with fibrin glue for treatment of malignant brain tumors].
Kawasaki H; Shimizu T; Takakura K; Umezawa Y
No Shinkei Geka; 1994 Sep; 22(9):819-25. PubMed ID: 8090263
[TBL] [Abstract][Full Text] [Related]
2. [An experimental study on antitumor effect of MMC-fibrin glue mixture].
Tanaka T; Yamana H; Fujita H; Ono T; Tou Y; Fujii T; Uhi T; Shirouzu K
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1400-2. PubMed ID: 8854763
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect of MMC mixed in Beriplast P].
Yano K; Matsuoka H; Baba H; Konoe S; Seo Y; Saito T; Tomoda H
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1629-31. PubMed ID: 7574778
[TBL] [Abstract][Full Text] [Related]
4. Advantages and safety of local treatment with MMC/Beriplast P for cancer tumors.
Matsuoka H; Yano K; Katsuta Y; Morita M; Kounoe S; Seo Y; Saito T; Tomoda H
Cancer Chemother Pharmacol; 1996; 38(6):508-12. PubMed ID: 8823491
[TBL] [Abstract][Full Text] [Related]
5. [Local chemotherapy for malignant brain tumors using methotrexate-containing fibrin glue].
Hirakawa W; Kadota K; Asakura T; Niiro M; Yokoyama S; Hirano H; Yatsushiro K; Kubota Y; Shimodozono Y
Gan To Kagaku Ryoho; 1995 May; 22(6):805-9. PubMed ID: 7755389
[TBL] [Abstract][Full Text] [Related]
6. Penetration of mitomycin C in human bladder.
Wientjes MG; Badalament RA; Wang RC; Hassan F; Au JL
Cancer Res; 1993 Jul; 53(14):3314-20. PubMed ID: 8324743
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic study of intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles].
Liang H; Tang HW; Hao XS; Sun H; Li W
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):412-5. PubMed ID: 16188126
[TBL] [Abstract][Full Text] [Related]
8. Taurolidine-Fibrin-Sealant-Matrix using spray application for local treatment of brain tumors.
Stendel R; Scheurer L; Schlatterer K; Gminski R; Möhler H
Anticancer Res; 2004; 24(2B):631-8. PubMed ID: 15161005
[TBL] [Abstract][Full Text] [Related]
9. In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin.
Cheung RY; Rauth AM; Ronaldson PT; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2006 Apr; 62(3):321-31. PubMed ID: 16330194
[TBL] [Abstract][Full Text] [Related]
10. Experimental study on bacterial colonization of fibrin glue and its prevention.
Tanemoto K; Fujinami H
Clin Ther; 1994; 16(6):1016-27. PubMed ID: 7697681
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice.
Fujita T; Tamura T; Yamada H; Yamamoto A; Muranishi S
J Drug Target; 1997; 4(5):289-96. PubMed ID: 9169985
[TBL] [Abstract][Full Text] [Related]
12. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth.
Patel VV; Zhao L; Wong P; Pradhan BB; Bae HW; Kanim L; Delamarter RB
Spine J; 2006; 6(4):397-403; discussion 404. PubMed ID: 16825045
[TBL] [Abstract][Full Text] [Related]
13. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.
Phillips RM; Burger AM; Loadman PM; Jarrett CM; Swaine DJ; Fiebig HH
Cancer Res; 2000 Nov; 60(22):6384-90. PubMed ID: 11103802
[TBL] [Abstract][Full Text] [Related]
14. Low dose suramin as a chemosensitizer of bladder cancer to mitomycin C.
Xin Y; Lyness G; Chen D; Song S; Wientjes MG; Au JL
J Urol; 2005 Jul; 174(1):322-7. PubMed ID: 15947683
[TBL] [Abstract][Full Text] [Related]
15. [Loco-regional cancer chemotherapy with a new drug delivery system, "anticancer drug-fibrin clot"].
Sugitachi A; Takatsuka Y; Numata N; Kawahara T; Hirata M; Kido T; Sakamoto I
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2814-7. PubMed ID: 2782891
[TBL] [Abstract][Full Text] [Related]
16. Polymeric prodrugs of mitomycin C designed for tumour tropism and sustained activation.
Seymour LW; Soyez H; De Marre A; Shoaibi MA; Schacht EH
Anticancer Drug Des; 1996 Jul; 11(5):351-65. PubMed ID: 8765529
[TBL] [Abstract][Full Text] [Related]
17. [A fibrin clot containing of anticancer drug for intra-arterial chemo-embolization therapy. (1) Experimental study on basic characteristics in dogs].
Itoh J; Nakagawa H; Sasaki H; Takahashi T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):250-7. PubMed ID: 3918503
[TBL] [Abstract][Full Text] [Related]
18. Fibrin glue system for adjuvant brachytherapy of brain tumors with 188Re and 186Re-labeled microspheres.
Häfeli UO; Pauer GJ; Unnithan J; Prayson RA
Eur J Pharm Biopharm; 2007 Mar; 65(3):282-8. PubMed ID: 17129715
[TBL] [Abstract][Full Text] [Related]
19. The neuroprotective effect of glial cell line-derived neurotrophic factor in fibrin glue against chronic focal cerebral ischemia in conscious rats.
Cheng H; Huang SS; Lin SM; Lin MJ; Chu YC; Chih CL; Tsai MJ; Lin HC; Huang WC; Tsai SK
Brain Res; 2005 Feb; 1033(1):28-33. PubMed ID: 15680336
[TBL] [Abstract][Full Text] [Related]
20. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
Qu QL; Zhang YG; Yang LZ; Sun L
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):257-60. PubMed ID: 16875622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
